Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:

NCT ID: NCT04426643 Completed - Clinical trials for Urinary Incontinence

Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells

Start date: August 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Treatment of patients with urinary incontinence after prostatectomy using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel

NCT ID: NCT04417413 Completed - Clinical trials for Pelvic Organ Prolapse

Safety and Efficacy of Non-ablative Er:YAG Laser Therapy for the Treatment of Pelvic Organ Prolapse and Coexisting Stress Urinary Incontinence: A Retrospective Case Series.

Start date: October 1, 2019
Phase:
Study type: Observational

The objective of the study is to retrospectively collect the data on patients who underwent pelvic organ prolapse treatment using a non-ablative Er:YAG laser with SMOOTH mode and to conduct an objective evaluation of safety and efficacy of Er:YAG laser treatment. In a group of patients that have concomitant stress urinary incontinence symptoms, the effectiveness of the treatments on these symptoms will be evaluated as well.

NCT ID: NCT04415710 Completed - Clinical trials for Urinary Incontinence

Pelvic Floor and Sexual Dysfunction in Women With Sjogren's Syndrome

Start date: February 21, 2019
Phase:
Study type: Observational [Patient Registry]

Sjogren's syndrome (SS) is a chronic, systemic, autoimmune disease characterized by lymphocytic infiltration of all exocrine glands, especially tear and salivary glands, and is more common in women.

NCT ID: NCT04412928 Completed - Clinical trials for Stress Urinary Incontinence

Factors Affecting the Cure of Overactive Bladder Syndrome in Women Underwent Mid-urethral Sling Procedure

Start date: April 13, 2020
Phase:
Study type: Observational

We will estimate the incidence of patients with overactive bladder syndrome after surgery and explore related predictors.

NCT ID: NCT04398186 Completed - Clinical trials for Polycystic Ovary Syndrome

The Effect of Polycystic Ovary Syndrome on Pelvic Floor Structure and Function

Start date: June 1, 2020
Phase:
Study type: Observational [Patient Registry]

Polycystic Ovarian Syndrome (PCOS) is the most common endocrinological disorder in women of reproductive age, and its prevalence is reported to be 6-21% in women aged 15-49 (1). Although its etiopathogenesis is still not clear, it is known that it is due to the disregulation of ovarian steroidogenesis under the influence of some environmental and genetic factors. Diagnosis of ESHRE / ASRM has set Rotterdam criteria in 2003; one of these criteria is the presence of hyperandrogenism (2). Hyperandrogenism leads to an increase in general muscle mass in the body (1, 3, 4). Pelvic floor muscles are associated with urethra in the anterior compartment, rectum and anus in the posterior compartment, and uterine support in the apex; major urinary and fecal continence ensuring its functions in order to stop in the appropriate position of the pelvic organs (5). The well-being of the pelvic floor muscle strength has a protective effect from urinary and fecal incontinence. It has been emphasized that the "anogenital distance" determined by the measurement of the anal region anterior to the clitoris anterior may also be a criteria in the diagnosis of Polycystic Ovary Syndrome (7,8,9). In this study, patients in the reproductive age between 18-40 years, who applied to our gynecology outpatient clinic and were diagnosed as PCOS according to Rotterdam criteria wil be study gorup and the women without PCOS will be control group. We aimed to evaluate the pelvic muscle strength with perineometry, to measure anogenital distance and to determine possible relationships with each other. In addition to demographic information, ICIQ-SF (Urinary incontinence inquiry short form) will also be taken to evaluate pelvic floor function (10).

NCT ID: NCT04369404 Completed - Overactive Bladder Clinical Trials

Impact of Decision Aids in Urogynecology

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

To evaluate how patient knowledge and confidence in decision making can be impacted by shared decision making in common urogynecology conditions.

NCT ID: NCT04366557 Completed - Clinical trials for Urinary Incontinence,Stress

The Influence of the Body Posture Correcting Therapy on Pelvic Floor Muscles Function

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the influence of the body posture correcting therapy on pelvic floor muscles function and urinary incontinence problem.

NCT ID: NCT04352647 Completed - Clinical trials for Urinary Incontinence

Observational Study on the Prevalence of Urinary Incontinence in Federates Athletes.

Start date: January 10, 2020
Phase:
Study type: Observational [Patient Registry]

To study the prevalence of urinary incontinence (UI) in female athletes from Castilla y León, as well as the category of athletics with the highest number of losses, the most incident risk factors and the bio-psycho-social consequences that it leads to.

NCT ID: NCT04351750 Completed - Clinical trials for Urinary Incontinence

Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Urinary incontinence (UI) symptoms are highly prevalent among women, and menopause is one of the risk factors for UI. During the menopausal transition, not only the hormonal secretion is changed but also the level of physical activity is affected. The time spent on physical activity is reduced in postmenopausal women. Studies have shown that physical activity acts in a bidirectional manner, exerting either a preventive or an aggravating effect on urinary incontinence. Individuals with sedentary lifestyle and insufficient physical activity (< 150 min/week) are at risk of developing UI, and regular physical activity exerts a protective effect in preventing UI, but the optimal type, duration, and intensity of exercise for the female older adult population remain unknown. In addition, objective measurements of pelvic floor muscle function is needed as the use of self-reported measures may cause response bias. The aim of the study is to investigate the effect of different intensity of exercise on pelvic floor muscle function and HRQoL in postmenopausal women with UI. The investigators hypothesize that (a) both high- and low-intensity physical activities can improve pelvic floor muscle strength and HRQoL in postmenopausal women with UI, and (b) the improvement in high-intensity group is higher than that in low-intensity group. A randomized trial will be conducted to compare the effect of different exercise intensity on pelvic floor muscle function in postmenopausal women with urinary incontinence (n=90).

NCT ID: NCT04348994 Completed - Clinical trials for Stress Urinary Incontinence

Long-term Effectiveness of Non-ablative Er: YAG Laser for Treatment of Stress Urinary Incontinence (SUI)

Start date: March 1, 2015
Phase: N/A
Study type: Interventional

Study is designed to assess the long-term clinical effects and safety profile of non-ablative Er:YAG (IncontiLase®) laser treatment, the durability of the results and the optimal treatment regimen for mild-to-severe stages of genuine female stress urinary incontinence (SUI).